Chronic Myeloproliferative Disorders Completed Phase 2 Trials for Methylprednisolone (DB00959)

IndicationStatusPhase
DBCOND0028462 (Chronic Myeloproliferative Disorders)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00053989Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Aplastic AnemiaTreatment
NCT00109993Campath-1H + FK506 and Methylprednisolone for GVHDSupportive Care
NCT00410657Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell TransplantSupportive Care